Bicyclic kinase inhibitors

Details for Australian Patent Application No. 2009289316 (hide)

Owner Novartis AG

Inventors Burger, Matthew; Lindvall, Mika

Agent Davies Collison Cave

Pub. Number AU-A-2009289316

PCT Pub. Number WO2010/026121

Priority 61/093,669 02.09.08 US

Filing date 31 August 2009

Wipo publication date 11 March 2010

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/47 (2006.01) - Quinolines

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

10 March 2011 PCT application entered the National Phase

  PCT publication WO2010/026121 Priority application(s): WO2010/026121

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009289317-Heterocyclic PIM-kinase inhibitors

2009289314-(meth)acrylate monomer, polymer, and coating agent